Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Kudelka AP, Levy T, Verschraegen CF, Edwards CL, Piamsomboon S, Termrungruanglert W, Freedman RS, Kaplan AL, Kieback DG, Meyers CA, Jaeckle KA, Loyer E, Steger M, Mante R, Mavligit G, Killian A, Tang RA, Gutterman JU, Kavanagh JJ. Kudelka AP, et al. Among authors: meyers ca. Clin Cancer Res. 1997 Sep;3(9):1501-5. Clin Cancer Res. 1997. PMID: 9815836 Clinical Trial.
Neurotoxicity of CI-980, a novel mitotic inhibitor.
Meyers CA, Kudelka AP, Conrad CA, Gelke CK, Grove W, Pazdur R. Meyers CA, et al. Clin Cancer Res. 1997 Mar;3(3):419-22. Clin Cancer Res. 1997. PMID: 9815700 Clinical Trial.
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA. Groves MD, et al. Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):127-35. doi: 10.1016/s0360-3016(99)00122-4. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477016 Clinical Trial.
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer.
Herbst RS, Madden TL, Tran HT, Blumenschein GR Jr, Meyers CA, Seabrooke LF, Khuri FR, Puduvalli VK, Allgood V, Fritsche HA Jr, Hinton L, Newman RA, Crane EA, Fossella FV, Dordal M, Goodin T, Hong WK. Herbst RS, et al. Among authors: meyers ca. J Clin Oncol. 2002 Nov 15;20(22):4440-7. doi: 10.1200/JCO.2002.04.006. J Clin Oncol. 2002. PMID: 12431966 Clinical Trial.
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Dabaja BS, et al. Among authors: meyers ca. Cancer. 2003 Sep 1;98(5):1021-8. doi: 10.1002/cncr.11627. Cancer. 2003. PMID: 12942571 Free article. Clinical Trial.
Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.
Tran HT, Blumenschein GR Jr, Lu C, Meyers CA, Papadimitrakopoulou V, Fossella FV, Zinner R, Madden T, Smythe LG, Puduvalli VK, Munden R, Truong M, Herbst RS. Tran HT, et al. Among authors: meyers ca. Cancer Chemother Pharmacol. 2004 Oct;54(4):308-14. doi: 10.1007/s00280-004-0816-z. Epub 2004 Jun 4. Cancer Chemother Pharmacol. 2004. PMID: 15184994 Clinical Trial.
220 results